<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906776</url>
  </required_header>
  <id_info>
    <org_study_id>CR 01/05</org_study_id>
    <nct_id>NCT00906776</nct_id>
  </id_info>
  <brief_title>Emdogain and Straumann Bone Ceramic in Infrabony Defects</brief_title>
  <official_title>Randomised, Controlled, Clinical Study to Compare the Effect of a Combination of Enamel Matrix Proteins and Straumann Bone Ceramic With Autogenous Bone in Deep-wide Intrabony Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised, controlled, clinical study to compare the effect of the combination of bone
      ceramic and enamel matrix proteins (test) versus autogenous bone graft alone (control) in the
      treatment of deep-wide intrabony defects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      30 subjects (15 test and 15 control) diagnosed with moderate to severe periodontitis
      (Armitage, 1999) will be enrolled in the study and randomized to either the test or the
      control group.

      The surgical procedure shall be performed within 15 days from the baseline visit of the
      subjects and will be the same for both groups. In both groups, the flap is replaced
      subsequently.

      In total 5 visits per patient are scheduled in this study. The total study duration for each
      patient should be 12 +/- 2 weeks.

      The study devices Emdogain® and Straumann Bone Ceramic are CE-marked, and approved by the
      FDA.

      One center in France will participate.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty to recruit patients fulfilling inclusion criteria
  </why_stopped>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Clinical Attachment Level (CAL)</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing Pocket Depth (PPD)</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Attachment Level (CAL)</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing Pocket Depth (PPD)</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Emdogain PLUS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autogenous bone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autogenous bone from the patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emdogain PLUS</intervention_name>
    <description>Emdogain treatment followed by Straumann Bone Ceramic application during periodontal surgery</description>
    <arm_group_label>Emdogain PLUS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autogenous bone</intervention_name>
    <description>Autogenous bone application during periodontal surgery</description>
    <arm_group_label>Autogenous bone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females must be at least 18 years and not more than 75 years of age

          -  The patient will have to be able to understand and sign the informed consent prior to
             starting the study.

          -  The patient also will have to have the ability and the willingness to comply with all
             study requirements.

          -  The patients will be in good general health without any systemic diseases.

          -  The teeth included in the study will be mandibular molars, maxillary and mandibular
             premolars, and canines.

          -  The patients will have to have at least one defect with pocket depth ≥ 5 mm.

          -  Intra-bony defects will have to have 1 or 2-wall morphology (at least 2/3 of the
             defect).

          -  Depth of the intrabony component of at least 3 mm

          -  The selected sites will have to have vertical intra-bony component ≥ 3 mm and an angle
             ≥ 30 degrees as assessed from standardized intra-oral radiographs.

          -  Oral hygiene parameters: Plaque Index (PI) ≤ 20 % and bleeding on probing (BoP) ≤ 20%

        Exclusion Criteria:

          -  Heavy smokers: more than 20 cigarettes per day

          -  Mucosal diseases such as erosive lichen planus

          -  History of local radiation therapy

          -  Presence of oral lesions (such as ulceration, malignancy)

          -  Teeth with untreated endodontic or cardiologic problems

          -  Physical handicap that will interfere with patient's ability to exercise good oral
             hygiene on a regular basis.

          -  Patients presenting antibiotic treatment within the 3 months preceding the surgical
             procedure.

          -  Patients using anti-inflammatory drugs on a regular basis.

          -  Intra-bony defects with a 3-wall morphology.

          -  Intra-bony defects with furcation involvement.

          -  Incisors and maxillary molars, will be excluded.

          -  Alcoholism or chronically drug abuse causing systemic compromize

          -  Medical conditions requiring prolonged use of steroids

          -  Current pregnancy at the time of recruitment and/or breastfeeding women.

          -  Conditions or circumstances, in the opinion of the investigator, which could represent
             a general contra-indication for surgical procedure or would prevent completion of
             study participation or interfere with analysis of study results, such as history of
             non-compliance, or unreliability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Bouchard, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rotschild Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôtel-Dieu, Université Paris 7 Denis Diderot</name>
      <address>
        <city>Paris</city>
        <zip>75006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <results_first_submitted>August 30, 2012</results_first_submitted>
  <results_first_submitted_qc>October 2, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2012</results_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="P2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="B2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.9" spread="8.9"/>
                    <measurement group_id="B2" value="31.9" spread="8.6"/>
                    <measurement group_id="B3" value="34.8" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Clinical Attachment Level (CAL)</title>
        <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level (CAL)</title>
          <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.86" spread="1.43"/>
                    <measurement group_id="O2" value="-2.44" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.02" spread="1.80"/>
                    <measurement group_id="O2" value="-2.13" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Probing Pocket Depth (PPD)</title>
        <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Pocket Depth (PPD)</title>
          <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.36" spread="1.42"/>
                    <measurement group_id="O2" value="-2.75" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Clinical Attachment Level (CAL)</title>
        <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level (CAL)</title>
          <description>CAL is calculated as the sum of Probing Pocket Depth (PPD) and Recession (REC). PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket. REC is measured using a periodontal probe from the gingival margin to the cemento-enamel junction (CEJ).</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.44" spread="0.95"/>
                    <measurement group_id="O2" value="-2.25" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Probing Pocket Depth (PPD)</title>
        <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Pocket Depth (PPD)</title>
          <description>PPD is measured using a periodontal probe from the gingival margin to the bottom of the pocket.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.78" spread="1.18"/>
                    <measurement group_id="O2" value="-2.56" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
        <time_frame>Baseline and 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain PLUS</title>
            <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
          </group>
          <group group_id="O2">
            <title>Autogenous Bone</title>
            <description>Autogenous bone from the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Between the Cementum-enamel-junction and the Base of the Vertical Bone Defect</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.26" spread="1.99"/>
                    <measurement group_id="O2" value="-2.29" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Emdogain PLUS</title>
          <description>Straumann Emdogain in combination with Straumann BoneCeramic</description>
        </group>
        <group group_id="E2">
          <title>Autogenous Bone</title>
          <description>Autogenous bone from the patient</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Philippe Bouchard</name_or_title>
      <organization>Rotschild hospital</organization>
      <phone>+33614656947</phone>
      <email>phbouch@noos.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

